Momenta Pharmaceuticals Announces Date for Second Quarter 2016 Financial Results Conference Call and Webcast
July 21 2016 - 8:00AM
Momenta Pharmaceuticals, Inc. (NASDAQ:MNTA), a biotechnology
company specializing in the characterization and engineering of
complex drugs, will release its financial results for the second
quarter ended June 30, 2016 before the U.S. financial markets open
on Thursday, August 4, 2016.
Management will host a conference call on that date
at 10:00 a.m. EDT to discuss these results and provide an update on
the company. To access the call, please dial (877) 224-9084
(domestic) or (720) 545-0022 (international) prior to the scheduled
conference call time and provide the access code 48928761. A live
webcast of the call will be available on the "Investors" section of
the company's website, www.momentapharma.com. Please go to the site
at least 15 minutes prior to the call in order to register,
download, and install any necessary software. An archived version
of the webcast will be posted on the Momenta website approximately
two hours after the call.
About MomentaMomenta
Pharmaceuticals is a biotechnology company specializing in the
detailed structural analysis of complex drugs and is headquartered
in Cambridge, MA. Momenta is applying its technology to
the development of generic versions of complex drugs, biosimilar
and potentially interchangeable biologics, and to the discovery and
development of novel therapeutics for oncology and autoimmune
indications.
To receive additional information about Momenta,
please visit the website at www.momentapharma.com, which does
not form a part of this press release.
Our logo, trademarks, and service marks are the
property of Momenta Pharmaceuticals, Inc. All other trade names,
trademarks, or service marks are property of their respective
owners.
Contact:
Sarah Carmody
Momenta Pharmaceuticals
1-617-395-5189
IR@momentapharma.com
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Mar 2024 to Apr 2024
Momenta Pharmaceuticals (NASDAQ:MNTA)
Historical Stock Chart
From Apr 2023 to Apr 2024